~~<i id='8D12AD848B'><strike id='8D12AD848B'><tt id='8D12AD848B'><pre id='8D12AD848B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

fashion

author：knowledge 2025-10-01 04:12:57 - browse：5

Bruce Broussard. -- health business coverage from STAT — Humana CEO Bruce Broussard Jason DeCrow/AP

Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading the company for more than a decade.

Humana named Jim Rechtin — who is the CEO of Envision Healthcare, the controversial physician staffing firm that is working its way through bankruptcy — as Broussard’s replacement. Rechtin will serve as president and chief operating officer starting Jan. 8 and then take over as CEO in the “latter half of 2024,” the company said in a news release.

Humana’s stock fell by more than 2% on the news Wednesday morning.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： NEJM study link tiny plastics in blood vessels to heart problems

entertainment

Wikipedia

knowledge

focus

JustinKlee(left)andJoshuaCohenaretheco-foundersandco-CEOsofAmylyxPharmaceuticals.KayanaSzymczakforST

WSS

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Change Healthcare cyberattack prompts Medicare loan program

Anavex keeps shifting the goalposts in its clinical trials

With psoriasis trial ahead, Alumis raises $259 million

Police still searching for prisoner who escaped from NYC hospital

NIH trials fail to test meaningful long Covid therapies, experts say

explore

fashion

entertainment

How to save PrEP access — and even expand it

Emergent cuts jobs, executive role in business shake

Medicare details structure of new drug price negotiation program

Air quality improving but still lags in Black, Hispanic communities

Cancer drug shortages should be causing more outrage

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Bright Health sells Medicare Advantage business to Molina

Emergent cuts jobs, executive role in business shake

The cancer drug shortage isn’t new — and neither are the solutions

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

entertainment

First medicine developed to treat MASH expected to be approved soon

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Police still searching for prisoner who escaped from NYC hospital

Naloxone nonprofit donates 200,000 doses after FDA approval

Amylyx ALS drug failure raises questions and concerns

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Wikipedia

Wikipedia

knowledge

focus